Early use of V2 receptor antagonists is associated with a shorter hospital stay and reduction in in-hospital death in patients with decompensated heart failure-Reference-Cited by-同舟云学术

Early use of V2 receptor antagonists is associated with a shorter hospital stay and reduction in in-hospital death in patients with decompensated heart failure

Published:2015-12-16 Issue:10 Volume:31 Page:1650-1658
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Matsukawa Ryuichi,Kubota Toru,Okabe Masanori,Yamamoto Yusuke

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-015-0780-z.pdf

Reference18 articles.

1. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure. JACC 62(16):e147–e239

2. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW (2007) Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 153(6):1021–1028

3. Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S, Goto D, Takeshita A (2007) Characteristics and outcomes of patients with heart failure in general practices and Hospitals Japanese Cardiac Registry of Heart Failure in General Practice (JCARE-GENERAL). Circ J 71(4):449–454

4. Sato N, Kajimoto K, Asai K, Mizuno M, Minami Y, Nagashima M, Murai K, Muanakata R, Yumino D, Meguro T, Kawana M, Nejima J, Satoh T, Mizuno K, Tanaka K, Kasanuki H, Takano T (2010) Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data. Am Heart J 159(6):949–955

5. Shiba N, Shimokawa H (2011) Prospective care of heart failure in Japan: lessons from CHART studies. EPMA J 2(4):425–438

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of door‐to‐tolvaptan time on short‐term clinical outcome in patients with acute heart failure;ESC Heart Failure;2023-09-26

2. The characteristics and outcomes in patients with acute heart failure who used tolvaptan: from KCHF registry;ESC Heart Failure;2023-08-29

3. Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart Failure;Journal of Clinical Medicine;2023-04-24

4. Early Commencement and Long-Term Continuation of Tolvaptan Treatment Attenuate Functional Impairment of Renal Vasopressin V2 Receptors and Improve Clinical Outcomes in Patients with Heart Failure;International Heart Journal;2023-03-31

5. Reply to Letter Regarding Article, "Simple Score to Predict Treatment Response to Low-Dose Tolvaptan in Patients with Heart Failure";International Heart Journal;2022-09-30